Stoke Therapeutics Inc (STOK): Rasio kapitalisasi pasar marang pendapatan
Stoke Therapeutics (STOK) is implementing RNA therapy to correct protein deficiency in the treatment of vision pathologies and epilepsy. The business relies on a narrow circle of oligonucleotide suppliers, minimizing risks through strategic alliances. High scientific potential and investments in TANGO technology are confirmed by the company's revenue valuation, where the metric settled at 60.40, reflecting market sentiment.
Stoke (STOK) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi bursa:
- indikator kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Stoke Therapeutics|STOK - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Stoke Corp|STOK - Gunggung utang perusahaan|Utang marang modal buku Stoke|STOK - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Stoke Therapeutics|Indikator likuiditas cepet stoketherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
STOK - Bathi resik perusahaan|Prakiraan bathi perusahaan Stoke Therapeutics|STOK - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Stoke Therapeutics Inc|STOK - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Stoke|STOK - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Stoke Therapeutics|STOK - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan stoketherapeutics.com|STOK - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Stoke Therapeutics
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:stoketherapeutics.com
Professional selection of sustainable assets requires aligning market capitalization with actual cash flows from sales. By analyzing the P/S multiple, an investor evaluates the value of each unit of revenue for Stoke Therapeutics (STOK), which, combined with the team's authority in RNA therapies and successful R&D results, confirms the validity of current market expectations and the fundamental reliability of the business.
Perusahaan pesaing
TEM - Rega marang dodolan|Rasio rega marang pendapatan Qiagen QGEN|Rasio kapitalisasi pasar marang pendapatan IONS|Repligen Corp. - Multiplikator P/S|RNA - Multiplikator P/S|CRISPR Therapeutics AG (CRSP) - Rasio rega marang pendapatan|Rasio rega marang dodolan WGS (genedx.com)|RARE (Ultragenyx) - Multiplikator P/S|Rega marang dodolan Beam Therapeutics Inc BEAM|Kapitalisasi marang pendapatan SRPT (Sarepta Therapeutics Inc)|Multiplikator P/S Twist Bioscience Corp (TWST)|10x Genomics, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NTLA (intelliatx.com)|BioLife Solutions - Multiplikator P/S|Koefisien rega marang pendapatan Wave Life Sciences Ltd WVE|MAZE: Multiplikator P/S|Kapitalisasi marang pendapatan Sionna Corp|Rasio rega marang pendapatan Prime Medicine, Inc.|tayshagtx.com (TSHA) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan uniQure (QURE)|Koefisien rega marang pendapatan MeiraGTx Holdings|Regenxbio - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SLDB (Solid Corp)|OCGN - Rasio rega marang pendapatan|Rega marang dodolan pacb.com|Benitec Biopharma (BNTC) - Rasio rega marang pendapatan|Design Therapeutics Inc (DSGN) - Multiplikator P/S|RCKT (Rocket Pharmaceuticals Inc) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan FDMT (4D Molecular Corp)|Rasio rega marang pendapatan Lexeo Therapeutics (LXEO)|korrobio.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S EDIT (Editas Medicine)|Multiplikator P/S Silence Therapeutics PLC SLN|PRQR - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Codexis, Inc. CDXS|SGMO (Sangamo Therapeutics) - Kapitalisasi marang pendapatan|NAUT: Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Metagenomi|Rega marang dodolan precisionbiosciences.com DTIL|Rasio rega marang pendapatan Generation Bio Co. (GBIO)|Multiplikator P/S Boundless Bio Inc (BOLD)|Multiplikator P/S XCUR (Exicure)|Imunon Inc (IMNN) - Rega marang dodolan|PHIO: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan MBIO (Mustang Bio, Inc.)|RNAZ (transcodetherapeutics.com) - Kapitalisasi marang pendapatan|BNGO: Kapitalisasi marang volume dodolan|APDN (Applied DNA Sciences) - Multiplikator P/S|BLUE: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S IPA|OMGA - Rega marang dodolan|Rasio rega marang pendapatan Singular Genomics Systems Inc OMIC|Rasio kapitalisasi pasar marang pendapatan RGLS|Syros Pharmaceuticals - Multiplikator P/S|TBIO - Multiplikator P/S|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rasio rega marang dodolan UBX (Unity Biotechnology Inc.)
